Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1 Results

Intervention Indication Therapeutic Area Year Actions
Pegargiminase in addition to pemetrexed and cisplatin for advanced malignant pleural mesothelioma – first line Cisplatin (Platinol) , Pegargiminase (ADI-PEG 20) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Malignant pleural mesothelioma (MPM) Lung and Respiratory Cancer 2018 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications